PAPER Ashabi G, Ahmadiani A, Abdi A, Abraki SB, Khodagholi F
SEARCH RESULTS
330988 RESULTS
PAPER Lambracht-Washington D, Rosenberg RN
Advances in the development of vaccines for Alzheimer's disease.
Discov Med. 2013 May;15(84):319-26. PubMed: 23725605PAPER Singh M, Simpkins JW, Bimonte-Nelson HA, Brinton RD
Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease.
Brain Res. 2013 Jun 13;1514:1-2. PubMed: 23726132PAPER Zamboni G, Wilcock GK, Douaud G, Drazich E, McCulloch E, Filippini N, Tracey I, Brooks JC, Smith SM, Jenkinson M, Mackay CE
Resting functional connectivity reveals residual functional activity in Alzheimer's disease.
Biol Psychiatry. 2013 Sep 1;74(5):375-83. PubMed: 23726515PAPER Massimo L, Evans LK, Benner P
Caring for loved ones with frontotemporal degeneration: The lived experiences of spouses.
Geriatr Nurs. 2013 Jul-Aug;34(4):302-6. PubMed: 23726759PAPER Giuliani D, Ottani A, Zaffe D, Galantucci M, Strinati F, Lodi R, Guarini S
Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
Neurobiol Learn Mem. 2013 Sep;104:82-91. PubMed: 23726868PAPER Peterson D, Munger C, Crowley J, Corcoran C, Cruchaga C, Goate AM, Norton MC, Green RC, Munger RG, Breitner JC, Welsh-Bohmer KA, Lyketsos C, Tschanz J, Kauwe JS,
Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study.
Alzheimers Dement. 2013 May 30; PubMed: 23727081PAPER Flynn JM, Melov S
SOD2 in mitochondrial dysfunction and neurodegeneration.
Free Radic Biol Med. 2013 Sep;62:4-12. PubMed: 23727323PAPER Son JH, Han DH, Min KJ, Kee BS
Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer's disease.
Neurosci Lett. 2013 Aug 26;548:15-20. PubMed: 23727389PAPER Di Francesco A, Arosio B, Gussago C, Dainese E, Mari D, D'Addario C, Maccarrone M
Involvement of 5-lipoxygenase in Alzheimer's disease: a role for DNA methylation.
J Alzheimers Dis. 2013 Jan 1;37(1):3-8. PubMed: 23727898PAPER Cui L, Zhang Y, Cao H, Wang Y, Teng T, Ma G, Li Y, Li K
Ferulic Acid Inhibits the Transition of Amyloid-β42 Monomers to Oligomers but Accelerates the Transition from Oligomers to Fibrils.
J Alzheimers Dis. 2013 Jan 1;37(1):19-28. PubMed: 23727899PAPER Kashima Y, Miyazawa M
Structure-activity relationships for bergenin analogues as β-secretase (BACE1) inhibitors.
J Oleo Sci. 2013;62(6):391-401. PubMed: 23728330PAPER Abuhassan K, Coyle D, Belatreche A, Maguire L
Compensating for synaptic loss in Alzheimer's disease.
J Comput Neurosci. 2013 Jun 2; PubMed: 23728490PAPER Birks J, McGuinness B, Craig D
Rivastigmine for vascular cognitive impairment.
Cochrane Database Syst Rev. 2013;5:CD004744. PubMed: 23728651PAPER Richter M, Hoffmann R, Singer D
T-cell epitope-dependent immune response in inbred (C57BL/6J, SJL/J, and C3H/HeN) and transgenic P301S and Tg2576 mice.
J Pept Sci. 2013 Jul;19(7):441-51. PubMed: 23728915Current Filters
No filters selected